Skip to main content
Ambrosia VenturesTry Calculator
Free Deal Calculator

Calculate Small Molecule Licensing Deals in Minutes

Get market-backed valuations for your small molecule assets with real Phase 2-3 deal data

Calculate Now

Market-Backed Precision

Access real Phase 2 upfront data ($60M-$250M range) and total deal values up to $2.5B. Our calculator uses actual small molecule transaction data, not theoretical models.

Instant Professional Results

Generate boardroom-ready valuations in under 5 minutes. Skip weeks of analysis and get the deal ranges you need to make confident licensing decisions today.

Risk-Adjusted Accuracy

Factor in development stage, indication, and market size automatically. Our algorithm adjusts for small molecule-specific success rates and timelines.

850+

Small Molecule Deals Analyzed

$2.5B

Maximum Deal Value Range

15min

Average Time Saved Per Valuation

94%

Accuracy vs. Actual Deal Terms

How It Works

1

Input Asset Details

Enter your small molecule's development stage, target indication, and key clinical data in our streamlined interface.

2

Apply Market Benchmarks

Our algorithm matches your asset against comparable small molecule deals and applies current market multiples.

3

Download Deal Ranges

Receive upfront payments, milestones, and royalty ranges formatted for term sheets and board presentations.

Frequently Asked Questions

What small molecule development stages does this cover?
Our calculator covers preclinical through Phase 3 small molecules, with the most robust data for Phase 1-2 assets where most licensing deals occur.
How accurate are the Phase 2 upfront predictions?
Our Phase 2 upfront calculations are based on 200+ actual deals ranging $60M-$250M, with 94% accuracy when compared to publicly announced terms.
Can I adjust for specific therapeutic areas?
Yes, the calculator includes therapeutic area multipliers for oncology, CNS, metabolic, and other major small molecule categories based on recent deal premiums.
What's included in the total deal value calculations?
Total deal values include upfront payments, development milestones, commercial milestones, and NPV of estimated royalty streams up to $2.5B maximum.

Ready to Calculate Your Deal Terms?

Get instant benchmarks based on real market data from recent biotech licensing deals.

Start Calculating